19 Jul AviadoBio
Lisa Deschamps, CEO
Oct. 7 | 11:30am | FLW Ballroom G
London, UK
(Private)
At AviadoBio, we are relentlessly chasing cures by translating groundbreaking science and precision delivery into potentially life-changing medicines for people living with neurological disease, beginning with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). With our deep understanding of the brain and suite of proprietary gene therapy platforms and innovative delivery technologies, we are working to overcome the challenges of delivering the right drug to the right place. Our innovative, neuroanatomy-led approach is designed to maximize the therapeutic potential of gene therapy to halt or potentially even reverse neurodegenerative diseases. Our rich heritage in academia is complemented by a strong leadership team with extensive gene therapy development and commercialization experience.
